To summarize major factors affecting fertility in obesity.
The worldwide epidemic of obesity
We are facing a worldwide public health emergency due to the increasing epidemic of obesity and related disorders [1] . Recent estimates show that the increasing prevalence of obesity is recognized worldwide, with few exceptions. The International Obesity TaskForce estimates that at least 1.1 billion adults are currently overweight, including 312 million who are obese, and that with the new Asian body mass index (BMI) criteria, the number is even higher [2] . Most importantly, there is emerging evidence that overweight is increasing not only in adults, but in children too [2] .
The price of obesity is represented by a long list of comorbidities and social, psychological and demographic problems. Obese women are characterized by similar comorbidities to men, particularly type 2 diabetes mellitus and cardiovascular diseases [3] . On the other hand, they also have some specific problems, including fertilityrelated disorders [4, 5] . Obesity affects every aspect of reproduction in both males and females. Undoubtedly, social and cultural factors are to be considered while estimating these effects, particularly in women. Fertility and reproduction unfortunately have a well-defined biological time interval, which is shorter than life expectancy, at least in industrialized and developed countries. This can undoubtedly expose women to a greater impact of negative environmental and biological factors and events, such as obesity, type 2 diabetes mellitus, and hypertension. Although there are very few studies on this topic, it is possible that this might also apply to men.
Obesity and infertility in women
Obesity may affect infertility and reproduction in women in different ways: (a) by affecting spontaneous ovulation, (b) by interfering with the efficiency and outcomes of assisted reproductive technology (ART), and (c) by worsening the physiological process and delivery in pregnancy.
Obesity and menstrual and ovulatory disorders
The association between obesity and alterations in female reproductive functions was recognized a long time ago [6, 7] , and has been confirmed more recently [8] .
The relationship between excess body fat and reproductive disorders appears to be stronger for early-onset obesity particularly during the adolescent age [9] . There are several epidemiological studies that suggest that changes in body weight or body composition are critical factors regulating pubertal development in young women and the discovery of leptin provided critical evidence for an endocrine regulation of puberty and the fertile reproductive system, particularly in females [10] . Age of menarche generally occurs at a younger age in obese girls than in normal-weight counterparts [9] , and there is evidence that in adolescent and young women the age of onset of obesity and of menstrual irregularities and oligo-anovulation are significantly correlated [9, 11] , Although many multiparous women are obese, there is nonetheless evidence that obesity may also affect fertility rates in women of fertile age. The Nurses' Health Study [12] reported that the risk of ovulatory infertility increased in women with increasing BMI values. Several other cross-sectional and prospective studies have produced similar findings (reviewed in [4] ). In a recent observational study performed in the UK [13] , the authors found that lifestyle (smoking, alcohol and coffee consumption) and BMI had a significant and cumulative dose-dependent and weight-dependent negative impact on fecundity.
The abdominal pattern of fat distribution may have a specific impact on ovulation and fertility. In one study examining a large group of nulliparous healthy women who presented for artificial insemination due to infertility of their partners, Zaadstra and coworkers [14] found that abdominal fatness was associated with a decreasing chance of conception more negatively than total body fat.
The paradigm of polycystic ovary syndrome: independent effects of obesity on fertility and reproduction Although they are not included in the current diagnostic criteria of polycystic ovary syndrome (PCOS) [15, 16] , it has nonetheless been widely recognized that insulin resistance and hyperinsulinemia, as well as obesity and the metabolic syndrome, affect most women with PCOS [17] [18] [19] . The prevalence of obesity in women with PCOS appears to be much greater than expected in the general population. Although the cause of this association remains unknown, a recent comprehensive review by Ehrmann [18] reported an estimated prevalence rate of more than 30% of cases and, in some series, a percentage as high as 75%.
Mechanisms by which obesity influences the pathophysiology and clinical expression of PCOS are complex and not completely understood [20, 21 ] . However, obesity is believed to play a distinct pathophysiological role in the development of hyperandrogenism in women with PCOS [17, 21 ] . Several factors are relevant to understanding the complex pathophysiological network relating obesity with PCOS. They include insulin, the insulingrowth-factor system, the opioid system, estrogens and several cytokines, particularly leptin, which have been reviewed extensively in recent articles, to which interested readers can refer [19,20,21 ,22] .
The phenotype of PCOS largely depends on the presence of obesity [17, 20] . Androgen abnormalities are usually more pronounced, despite lower luteinizing hormone concentrations in PCOS patients of normal weight. This is particularly evident in those with central fat disposition, which characterizes more than 60% of women with PCOS, even if they have normal BMI values. In addition, a higher proportion of obese women with PCOS complain of hirsutism and menstrual disorders in comparison with normal-weight women. Chronic oligo-anovulation is likely more pronounced in obese women with PCOS, although longitudinal studies on this specific topic have not been performed.
The relative contribution of the long list of metabolic derangements in influencing ovulation and fertility in PCOS has been discussed in recent reviews [20,21 ,23] . Other than ovulatory dysfunctions, obese women with PCOS are characterized by blunted responsiveness to pharmacological treatments to induce ovulation, recurrent miscarriages, more frequent early pregnancy loss and a reduced incidence of pregnancy. Finally, from recent studies performed in women with PCOS conceiving after ART, there is evidence that those with obesity had higher gonadotropin requirements during stimulation, fewer oocytes, a higher abortion rate and a lower live-birth rate than their nonobese counterparts [20, 21 ] . Therefore, a decreased efficiency of the different treatments for anovulation and infertility may be expected in obese women with PCOS.
Obesity and assisted reproductive technology outcomes
Obesity can impair the outcome of ART. It has been reported that, by raising BMI by one unit, the odds for pregnancy decrease by 0.84 in in-vitro fertilization (IVF) and that each reduction of BMI by one unit after lifestyle intervention increases the chance of pregnancy by 1.19 [24 ] .
Obesity-related alterations to steroid metabolism and altered secretion and action of insulin and several adipokines may in fact affect follicle growth, embryo development and implantation in natural conception or following ART [24 ,25,26] . Higher gonadotropin requirements in obese women undergoing controlled ovarian hyperstimulation for ART are necessary, which suggests some degree of resistance to exogenous gonadotropin resistance [27] , particularly when PCOS is also involved [28] .
Longer periods of ovarian stimulation and higher cancellation rates and higher incidence of follicular asynchrony have been found in obese patients undergoing controlled ovarian hyperstimulation and IVF [24 ,29] . Different studies have shown that decreased periovulatory human chorionic gonadotrophin (hCG) concentrations and an inverse correlation between intrafollicular hCG levels and BMI. These findings were associated with diminished fertilization rates [30] , and that lower peak estradiol concentrations noted in obese women undergoing controlled ovarian hyperstimulation for IVF was associated with an impaired cycle outcome [31] .
Reduced oocyte retrieval in overweight and obese women has been reported [27] , mainly due to their poorer ovarian response, and even when PCOS is associated [24 ] .
Oocyte quality can also be impaired as a result of obesity, which implies lower fertilization rates [27] , although similar data have been not reported by others [24 ] . Whether poorer embryo quality may be associated with obesity is unclear, as positive and negative [24 ,28,29] reports have been published. Finally, a lower incidence of embryo transfer and lower mean number of transferred embryos have been observed in linear association with increasing BMI in some, but not in all studies [24 ] .
Discrepancies in the current literature regarding reproductive outcome in obese patients may be due to the different cut-off points used to define obesity, and/or the inclusion of a combination of overweight and obese patients in some study populations, the type of obesity considered, and the individual endocrine and metabolic pattern of each woman, which is likely to vary among subjects within the same BMI group. In a recent metaanalysis performed by Maheshwari and colleagues [32 ] aimed at assessing the effects of obesity on the outcome of ART, they found that, compared with women with a BMI of 25 kg/m 2 or less, women with a BMI of more than 25 kg/m 2 have a lower chance of pregnancy following IVF (odds ratio 0.71), require higher doses of gonadotropins (weighted mean differences, 210.08) and have an increased miscarriage rate (odds ratio 1.31). By contrast, they found no evidence on the effect of BMI on live births, cycle cancellation, oocyte recovery and ovarial hyperstimulation syndrome. Overall, however, they suggest that further studies with clear entry criteria and uniform reporting of outcomes are needed to investigate the true impact of weight on the outcome of ART.
The oocyte donation model has still not definitively established this hypothesis, but recent studies are showing findings in this direction [24 ] . Since the impact of obesity on extraovarian factors and its influence on ART outcome continue to be a provocative issue [33] , further studies are needed.
Obesity and pregnancy outcome
Most reports show decreased live-birth rates in obese patients with spontaneous pregnancies or following ART. It has been suggested that obesity and associated hormonal alterations may affect the function of the corpus luteum and that of the trophoblast function, early embryo development and endometrial receptivity [24 ,32 ] . Implantation seems also to be negatively affected by obesity, although this is still controversial [27] . Furthermore, whether obese women have lower pregnancy rates following ovulation induction or ART is still controversial [24 ] . On the other hand, Wang et al. [34] showed that the probability of achieving at least one pregnancy during the ART treatment was reduced by almost 30% in women with a BMI of 30-35 kg/m 2 , and by 50% in those with a BMI greater than 35 kg/m 2 .
Miscarriages can occur more frequently in obese women not only following conceptions achieved through ART [27, 28, 34] , although there are some discrepancies. Although no consensus exists, it is commonly accepted that only those women with a BMI greater than 30 kg/m 2 should be considered at high risk [35 ] . Moreover, discrepancies between the studies could be related to the lack of differentiation according to fat distribution patterns [36] .
Obesity is also associated with a higher risk of obstetric causes of maternal death and of anaesthesia-related deaths [37] [38] [39] . Obese women present higher rates of complications in pregnancy, mainly in the third trimester, such as hypertension, preeclampsia, gestational diabetes, thromboembolism, urinary tract infection, fetal macrosomia, preterm labor and delivery, sudden and unexplained intrauterine death, operative vaginal deliveries, shoulder dystocia, cesarean-section delivery, anesthetic and surgical complications, postpartum hemorrhage, postoperative wound infection and dehiscence and endomyometritis in the puerperium [35 ,38] .
The negative impact of obesity can also be extended to fetal malformations, such as defects of the central nervous system (neural tube defects), great vessels, ventral wall and intestine [4, 37] . Apart from congenital anomalies, children of obese mothers run a higher risk of intrauterine fetal death, head trauma, shoulder dystocia, brachial plexus lesions, fractures of the clavicle, meconium aspiration, fetal distress and increased risk of death in the first year [35 ,38] .
Obesity and infertility in men
In men, obesity can affect fertility by altering the hormonal milieu and by reducing spermatogenesis. Moreover, infertility can also be determined by the increasing frequency of erectile dysfunction. These topics will be addressed in the following paragraphs.
Male obesity as a hypoandrogenic state
In the obese male, total and free testosterone blood concentration levels progressively decrease with increasing body weight, and this reduction is associated with a progressive decrease of sex hormone-binding globulin concentrations. Circulating levels of androstenedione and dihydrotestosterone are usually normal or slightly reduced. Changes in testosterone metabolism through 5a-reductase activity may also occur in obesity, although this is still questionable [40 ] . Abdominal fat distribution may have a further negative effect on testosterone levels in men [40 ,41] .
Factors responsible for altered androgen status in male obesity
Gonadotropin levels are usually normal or slightly reduced in obese men, as are their responses following luteinizing-hormone releasing hormone stimulation [42] . This specifically occurs in obese men with high BMI values, probably due to impaired secretion of the hypothalamic gonadotropin-releasing hormone [43] . The absence of classic clinical signs of hypogonadism can be explained by the fact that the testosterone-free fraction is only 2% of total testosterone, and that obesity predominantly affects circulating bound testosterone, due to the concurrent decrease of sex hormone-binding globulin production, as a result of hepatic synthesis inhibition by circulating insulin in excess [44] . However, as demonstrated in women, insulin may also stimulate testosterone production in vivo in men [40 ] . Therefore, reduced testosterone in male obesity is due to a balance of inhibiting and stimulating processes.
Estrogen production rates in male obesity are increased in proportion to body weight [45] . It has been suggested that hypotestosteronemia in obese men may in some way result from negative feedback, inhibiting the regulation of estrogen upon gonadotropin secretion [40 ] . Alternatively, higher aromatase activity has been hypothesized, based on the reversal of reduced testosterone levels after administration of an aromatase inhibitor, testolactone [40 ] .
As occurs in endogenous hypercortisolism, which is invariably associated with inhibition of the hypothalamo-pituitary-gonadal axis [40 ] , recent data support the concept that reduced testosterone in obese males may partly depend on a hyperactivity of the hypothalamo-pituitary-adrenal axis in obesity [46] .
Leptin receptors are in fact widely expressed in the human testes [47] . Long-term exposure of human fat cells to testosterone inhibits leptin expression in vitro [47] , and in male rodent cultured Leydig cells, leptin has been shown to negatively influence luteinizing hormone-and hCG-stimulated androgen production, by mechanisms probably involving 17-20 lyase activity [48] . Hypogonadal men show lowered leptin levels, which are restored to normal by testosterone-replacement therapy [49] . Studies in obese men have shown a significantly negative relationship between leptin levels and basal and hCG-stimulated testosterone levels [50] . This supports the theory that excess circulating leptin contributes in reducing testosterone levels in obese men.
Effect of obesity on reproduction in men
Despite the important impact of obesity on steroidogenesis, the impact of obesity on fertility in obese men has been much less investigated than in women. Epidemiological studies are lacking. Spermatogenesis and fertility may, however, be reduced in massively obese subjects [51] . On the other hand, there is emerging evidence for a growing subfertility condition in male obesity. This situation may be due to multiple factors. As reported above, this may be partly explained by the hypotestosteronemic state, which represents a true functional state of hypogonadotropic hypogonadism. In these conditions, oligospermia may also occur [40 ] .
One still underestimated problem is represented by erectile dysfunction, which is very common in obese men and tends to increase with increasing BMI values. In the Massachusetts Male Aging Study [52] , which was performed in a large cohort of men aged 40-70 years, the overall prevalence of erectile dysfunction was 17%, but it increased to 45% in subjects with BMI values greater than 30 kg/m 2 . In the Health Professionals Follow-up Study [53] , it was found that men with BMI higher than 28.7 kg/m 2 had a 30% higher risk for erectile dysfunction than those with a normal BMI (<25 kg/m 2 ). However, there are no studies on the prevalence of erectile dysfunction in obesity, although clinical studies indicate a very high prevalence [54, 55] . Interestingly, erectile dysfunction can be reversed by weight loss [56] . As erectile dysfunction represents an indirect but very common cause of infertility in men, this should be taken into consideration in the clinical background. This is further emphasized by the strong association between erectile dysfunction and type 2 diabetes mellitus and recent findings demonstrating that erectile dysfunction represents a risk factor for cardiovascular diseases [57] .
Conclusion
Altered fertility can represent the price paid by obese individuals of both sexes. This fact is emphasized by the fact that the search for fertility has been progressively delayed in the last two decades, particularly in western and industrialized countries, whereas the onset of obesity starts progressively earlier than in the past, often during adolescence and young age. Therefore, a negative impact of obesity on the reproductive system could have been expected a long time ago.
Mechanisms by which obesity, particularly the abdominal phenotype, affect the reproductive system are only partly understood, and should be investigated further. In particular, the role of environmental factors (i.e. endocrine disruptors etc.) merits more scientific attention than in the past. Of specific interest is the role of obesity in the development and pathophysiology of the PCOS. According to several clinical studies performed in different countries worldwide, the prevalence of PCOS in young females and those of the reproductive age is very high and will probably tend to increase more in the future. In western countries, the phenotype of women with PCOS is characterized by the presence of obesity, several metabolic disturbances, including insulin resistance and the metabolic syndrome, and a higher susceptibility to develop type 2 diabetes earlier than expected in the general population. Recognition of the fundamental role of obesity on PCOS may lead to investigation into its prevention in susceptible individuals, which, in turn, may improve fertility and prevent metabolic complications. More research efforts should be planned in this important area.
The role of obesity in pregnancy outcomes, including maternal and fetal problems, is often underestimated. Obesity in women can in fact increase the risk of miscarriages and impair pregnancy outcomes, even after ART, particularly when BMI exceeds 30 kg/m 2 . Moreover, a variety of maternal disorders and, most importantly, fetal problems are associated with obesity during pregnancy. Gynaecologists and obstetricians should invest in more research in this area and try exhaustively to favour the control of body weight in women wishing to conceive, particularly when ART is planned.
The impact of obesity on the reproductive system in men is probably more important than expected and involves alterations of the hypothalamo-pituitary-gonadal endocrine axis, erectile dysfunction and reduced semen quality. In massively obese individuals, reduced spermatogenesis associated with severe hypotestosteronemia may favour infertility. Moreover, the frequency of erectile dysfunction increases with increasing BMI. Finally, a potential pathophysiological effect of environmental endocrine disruptors on both fertility and obesity in men has been suggested.
